HimalayasHimalayas logo
Kura OncologyKO

Senior Director, Pharmacovigilance (Safety Science & Surveillance)

Kura Oncology is focused on developing targeted therapies for cancer with an emphasis on precision medicine.

Kura Oncology

Employee count: 51-200

Salary: 274k-330k USD

United States only

Stay safe on Himalayas

Never send money to companies. Jobs on Himalayas will never require payment from applicants.

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of.

At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics.

As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality.

To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.

ESSENTIAL JOB FUNCTIONS:

The Senior Director of Pharmacovigilance (PV), Safety Sciences & Surveillance, provides strategic and operational leadership for global safety surveillance activities across Kura’s clinical and post-marketing programs. This individual is responsible for signal detection and evaluation, benefit-risk assessment, and safety surveillance strategies, for the company’s products. This role ensures compliance with global pharmacovigilance regulations and drives proactive risk management to protect patients and support product development.

This position partners cross-functionally with Clinical Development, Nonclinical, Regulatory Affairs, Biostatistics, and Quality to ensure robust safety oversight throughout the product lifecycle

Strategic Leadership

  • Lead the Safety Sciences/Surveillance function, setting strategies for signal detection, risk management, and aggregate safety reporting.
  • Lead safety strategy contributions to regulatory submissions, and lifecycle management strategies.
  • Serve as safety lead on cross-functional governance committees (e.g., Safety Monitoring Committees).

Safety Surveillance & Signal Management

  • Drive the development and continuous evolution of safety signal detection methodologies and product-specific signaling strategies.
  • Lead signal validation, prioritization, and assessment processes in alignment with global regulations; interpretation of safety signals and trends; communication of safety assessments (written and verbal) of safety risks in collaboration with other functional stakeholders.

Risk Management & Regulatory Strategy

  • Provide strategic oversight for Risk Management Plans (RMPs), REMS (if applicable), and other risk minimization activities.
  • Serve as safety representative in interactions with global regulatory authorities.
  • Ensure inspection readiness and support health authority audits/inspections.

Aggregate Reporting & Safety Communications

  • Oversee preparation and review of aggregate safety reports (DSURs, PSURs/PBRERs, aggregate reports for anticipated events).
  • Ensure alignment of safety messaging across clinical, regulatory, and medical communications.
  • Provide strategic direction of safety content for key regulatory documents (e.g., DSURs, PSURs, IBs, protocols, RMPs) ensuring consistency and scientific rigor.

Cross-Functional Collaboration

  • Partner with Clinical Development on safety monitoring strategies and DMC interactions.
  • Collaborate with Biostatistics on integrated safety analyses.
  • Provide safety expertise to Medical Affairs and Commercial teams for post-marketing surveillance, as needed.

Compliance & Quality

  • Maintain oversight of safety vendors and CROs supporting surveillance activities.
  • Contribute to SOP development and continuous improvement of PV systems and processes.
  • Support inspection readiness activities, internal audits and external inspections.

Team Leadership

  • Mentor and develop a high-performing Safety Sciences team.
  • Foster a culture of scientific rigor, accountability, and patient focus.
  • Manage departmental budget and resource planning.

JOB SPECIFICATIONS:

  • PharmD or PhD in life sciences preferred.
  • Advanced clinical or regulatory training highly desirable.
  • 12+ years of experience in pharmacovigilance or drug safety.
  • 5+ years in leadership roles within Safety Sciences, Signal Detection, or Safety Surveillance.
  • Experience supporting global regulatory submissions and health authority interactions preferred.
  • Strong background in oncology required.
  • Experience in both clinical development and post-marketing safety preferred.
  • Strong knowledge of signal detection methodologies and benefit-risk assessment.
  • Experience in the principles and techniques of data analysis, proficient in the use of data analysis/visualization software.
  • Working knowledge of industry standard safety databases, Regulatory databases, and other electronic data capture systems; working knowledge of MedDRA and WHODrug dictionaries.
  • Proven experience authoring and reviewing aggregate safety reports.
  • Demonstrate a deep understanding of and ensure compliance with current global PV regulations (FDA, EMA, CIOMS, ICH E2 guidelines).
  • Strategic thinker, a self-starter with strong scientific judgment.
  • Executive presence and ability to influence cross-functional stakeholders.
  • Excellent written and verbal communication skills.

The base range for a Senior Director is $274,000 - $330,000 per year. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus.

Kura’s Values that are used for candidate selection and performance assessments:

  • We work as one for patients
  • We are goal-focused and deliver with excellence
  • We are science-driven courageous innovators
  • We strive to bring out the best in each other and ourselves

The Kura Package

  • Career advancement/ development opportunities
  • Competitive comp package
  • Bonus
  • 401K + Employer contributions
  • Generous stock options
  • ESPP Plan
  • 20 days of PTO to start
  • 18 Holidays (Including Summer & Winter Break)
  • Generous Benefits Package with a variety of plans available with a substantial employer match
  • Paid Paternity/Maternity Leave
  • In-Office Catered lunches
  • Home Office Setup
  • Lifestyle Spending Stipend
  • Commuter Stipend (Boston Office)
  • Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more!

Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The Company’s pipeline consists of small molecule drug candidates designed to target cancer signaling pathways. Ziftomenib, a once-daily, oral menin inhibitor, is the first and only investigational therapy to receive Breakthrough Therapy Designation from the U.S. Food and Drug Administration (“FDA”) for the treatment of relapsed/refractory (“R/R”) NPM1-mutant acute myeloid leukemia (“AML”). In November 2024, Kura Oncology entered into a global strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize ziftomenib for AML and other hematologic malignancies. Enrollment in a Phase 2 registration-directed trial of ziftomenib in R/R NPM1-mutant AML has been completed, and in the second quarter of 2025, the companies announced the FDA’s acceptance of a New Drug Application for ziftomenib for the treatment of adult patients with R/R NPM1-mutant AML and assignment of a Prescription Drug User Fee Act target action date of November 30, 2025. Kura Oncology and Kyowa Kirin are also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R/R NPM1-mutant and KMT2A-rearranged AML. KO-2806, a next-generation farnesyl transferase inhibitor, is being evaluated in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies for patients with various solid tumors. Tipifarnib, a potent and selective farnesyl transferase inhibitor, is currently in a Phase 1/2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma. For additional information, please visit Kura’s website at www.kuraoncology.com and follow us on X and LinkedIn.

Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.

If you are a California resident, please see the attached Privacy Notice CA Privacy Notice

About the job

Apply before

Posted on

Job type

Full Time

Experience level

Salary

Salary: 274k-330k USD

Experience

12 years minimum

Location requirements

Hiring timezones

United States +/- 0 hours

About Kura Oncology

Learn more about Kura Oncology and their company culture.

View company profile

Kura Oncology, Inc. is a clinical-stage biopharmaceutical company focused on the development of targeted therapies for cancer. The company is dedicated to realizing the promise of precision medicine in oncology, developing innovative treatment options that improve the lives of cancer patients.

Through a combination of industry-leading expertise and cutting-edge research, Kura Oncology is leveraging an extensive understanding of the molecular mechanisms of cancer. The company works relentlessly to discover and develop small molecule drug candidates that can selectively target specific mutations and pathways involved in cancer progression. Kura is particularly focused on the development of therapies that can provide meaningful benefits to patients with cancers that have been historically considered difficult to treat.

Employee benefits

Learn about the employee benefits and perks provided at Kura Oncology.

View benefits

Generous Vacation

Employees receive four weeks of vacation per year, increasing with tenure (up to 25 days).

Paid Holidays

Our offices are closed for major holidays, including an extended summer and end-of-year break.

Lifestyle Stipend

Kura provides a flexible $250 monthly lifestyle stipend that employees can use however they choose.

Home Office Setup Reimbursement

Home office setup reimbursement of up to $1,000 plus an annual refresh stipend of $250 paid out in Q4.

View Kura Oncology's employee benefits
Claim this profileKura Oncology logoKO

Kura Oncology

View company profile

Similar remote jobs

Here are other jobs you might want to apply for.

View all remote jobs

2 remote jobs at Kura Oncology

Explore the variety of open remote roles at Kura Oncology, offering flexible work options across multiple disciplines and skill levels.

View all jobs at Kura Oncology

Remote companies like Kura Oncology

Find your next opportunity by exploring profiles of companies that are similar to Kura Oncology. Compare culture, benefits, and job openings on Himalayas.

View all companies

Find your dream job

Sign up now and join over 100,000 remote workers who receive personalized job alerts, curated job matches, and more for free!

Sign up
Himalayas profile for an example user named Frankie Sullivan